CY1122959T1 - Συν-κρυσταλλοι αγομελατινης και π-τολουολοσουλφονικου οξεος, μεθοδος για την παρασκευη αυτων και οι φαρμακευτικες συνθεσεις αυτων - Google Patents
Συν-κρυσταλλοι αγομελατινης και π-τολουολοσουλφονικου οξεος, μεθοδος για την παρασκευη αυτων και οι φαρμακευτικες συνθεσεις αυτωνInfo
- Publication number
- CY1122959T1 CY1122959T1 CY20191100686T CY191100686T CY1122959T1 CY 1122959 T1 CY1122959 T1 CY 1122959T1 CY 20191100686 T CY20191100686 T CY 20191100686T CY 191100686 T CY191100686 T CY 191100686T CY 1122959 T1 CY1122959 T1 CY 1122959T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical compositions
- crystals
- preparation
- toluolesulfonic
- agomelatin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Η παρούσα εφεύρεση αφορά νέες μορφές συν-κρυστάλλων αγομελατίνης και p-τολουολοσουλφονικού οξέος, τη μέθοδο για παρασκευή αυτών και τις φαρμακευτικές συνθέσεις που τις περιέχουν. Οι συν-κρύσταλλοι σύμφωνα προς την εφεύρεση έχουν καλύτερη διαλυτότητα από ότι η αγομελατίνη και συνεπώς είναι περισσότερο 15 κατάλληλοι για ανάπτυξη φαρμακευτικών συνθέσεων. Αυτοί έχουν υψηλότερο επίπεδο σταθερότητας και καθαρότητας και επιπλέον λαμβάνονται με μία απλή μέθοδο που δεν περιλαμβάνει δύσκολα στάδια.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2013/080472 WO2015013903A1 (en) | 2013-07-31 | 2013-07-31 | NEW AGOMELATINE p-TOLUENESULFONIC ACID CO-CRYSTAL FORMS AND PREPARATION THEREOF |
| FR1360121A FR3012141B1 (fr) | 2013-10-17 | 2013-10-17 | Nouvelles formes de co-cristaux d'agomelatine et d'acide p-toluenesulfonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2014/051972 WO2015015118A2 (fr) | 2013-07-31 | 2014-07-30 | NOUVELLES FORMES DE CO-CRISTAUX D'AGOMELATINE ET D'ACIDE p-TOLUENESULFONIQUE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1122959T1 true CY1122959T1 (el) | 2021-10-29 |
Family
ID=51300781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100686T CY1122959T1 (el) | 2013-07-31 | 2019-07-01 | Συν-κρυσταλλοι αγομελατινης και π-τολουολοσουλφονικου οξεος, μεθοδος για την παρασκευη αυτων και οι φαρμακευτικες συνθεσεις αυτων |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9663451B2 (el) |
| EP (1) | EP3036218B1 (el) |
| JP (1) | JP6525996B2 (el) |
| AU (1) | AU2014298230C1 (el) |
| CA (1) | CA2918228C (el) |
| CY (1) | CY1122959T1 (el) |
| DK (1) | DK3036218T3 (el) |
| EA (1) | EA031053B1 (el) |
| ES (1) | ES2734562T3 (el) |
| HK (2) | HK1222167A1 (el) |
| HR (1) | HRP20191119T1 (el) |
| HU (1) | HUE044798T2 (el) |
| LT (1) | LT3036218T (el) |
| ME (1) | ME03388B (el) |
| MX (1) | MX369301B (el) |
| NZ (1) | NZ716153A (el) |
| PL (1) | PL3036218T3 (el) |
| PT (1) | PT3036218T (el) |
| RS (1) | RS58778B1 (el) |
| RU (1) | RU2695609C2 (el) |
| SG (1) | SG11201600005VA (el) |
| SI (1) | SI3036218T1 (el) |
| UA (1) | UA117023C2 (el) |
| WO (1) | WO2015015118A2 (el) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7498466B2 (en) * | 2004-02-13 | 2009-03-03 | Les Laboratoires Servier | Process for the synthesis and crystalline form of agomelatine |
| CN101481321B (zh) * | 2009-02-27 | 2012-04-18 | 上海医药工业研究院 | 阿戈美拉汀卤化氢复合物及其制备方法 |
| ES2429348T3 (es) * | 2011-04-28 | 2013-11-14 | Zentiva, K.S. | Cocristales farmacéuticamente aceptables de N-[2-(7-metoxi-1-naftil)etil]acetamida y procedimientos para su preparación |
| CN102702041B (zh) * | 2012-05-14 | 2013-08-14 | 上海右手医药科技开发有限公司 | 阿戈美拉汀苯磺酸类复合物及其制备方法 |
| KR20150020191A (ko) | 2012-05-14 | 2015-02-25 | 상하이 라이트핸드 팜테크 주식회사 | 아고멜라틴 산기 복합체와 그의 제조방법 및 용도 |
-
2014
- 2014-07-30 US US14/908,253 patent/US9663451B2/en active Active
- 2014-07-30 EP EP14749937.0A patent/EP3036218B1/fr active Active
- 2014-07-30 ME MEP-2019-153A patent/ME03388B/me unknown
- 2014-07-30 SI SI201431215T patent/SI3036218T1/sl unknown
- 2014-07-30 HU HUE14749937 patent/HUE044798T2/hu unknown
- 2014-07-30 JP JP2016530589A patent/JP6525996B2/ja not_active Expired - Fee Related
- 2014-07-30 RS RS20190633A patent/RS58778B1/sr unknown
- 2014-07-30 NZ NZ716153A patent/NZ716153A/en not_active IP Right Cessation
- 2014-07-30 PL PL14749937T patent/PL3036218T3/pl unknown
- 2014-07-30 LT LTEP14749937.0T patent/LT3036218T/lt unknown
- 2014-07-30 PT PT14749937T patent/PT3036218T/pt unknown
- 2014-07-30 ES ES14749937T patent/ES2734562T3/es active Active
- 2014-07-30 WO PCT/FR2014/051972 patent/WO2015015118A2/fr active Application Filing
- 2014-07-30 EA EA201600143A patent/EA031053B1/ru not_active IP Right Cessation
- 2014-07-30 UA UAA201601716A patent/UA117023C2/uk unknown
- 2014-07-30 SG SG11201600005VA patent/SG11201600005VA/en unknown
- 2014-07-30 CA CA2918228A patent/CA2918228C/fr not_active Expired - Fee Related
- 2014-07-30 AU AU2014298230A patent/AU2014298230C1/en not_active Ceased
- 2014-07-30 RU RU2016106954A patent/RU2695609C2/ru active
- 2014-07-30 MX MX2016001218A patent/MX369301B/es active IP Right Grant
- 2014-07-30 DK DK14749937.0T patent/DK3036218T3/da active
-
2016
- 2016-08-30 HK HK16110305.1A patent/HK1222167A1/zh not_active IP Right Cessation
- 2016-10-04 HK HK16111559.2A patent/HK1223348A1/zh unknown
-
2019
- 2019-06-19 HR HRP20191119TT patent/HRP20191119T1/hr unknown
- 2019-07-01 CY CY20191100686T patent/CY1122959T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121395T1 (el) | Τετραϋδροπυριδοπυραζινες-διαμορφωτες toy gpr6 | |
| CY1121776T1 (el) | C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων | |
| CL2018003323A1 (es) | Piridinas sustituidas con heteroarilo y métodos de uso. | |
| CY1124097T1 (el) | Κρυσταλλικο πολυμορφο της ελευθερης βασης της 2-υδροξυ-6-((2-(1-ισοπροπυλο-1η-πυραζολ-5-υλο)πυριδιν-3-υλο)μεθοξυ)βενζαλδεϋδης | |
| EA201890124A1 (ru) | Новые гидроксикислотные производные, способ их получения и фармацевтические композиции, содержащие их | |
| CY1119110T1 (el) | Ρυθμιστες ρ2χ7 | |
| CO2018013141A2 (es) | Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| EA201401292A2 (ru) | Новые тиенопиримидиновые производные, способ их получения и фармацевтические композиции, содержащие их | |
| EA201890126A1 (ru) | Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их | |
| EA201890123A1 (ru) | Новые аминокислотные производные, способ их получения и фармацевтические композиции, содержащие их | |
| EA201891622A1 (ru) | Новые производные аммония, способ их получения и фармацевтические композиции, содержащие их | |
| CU20180001A7 (es) | Derivados de oxopiridina sustituidos y procesos para su preparación | |
| EA201890752A1 (ru) | Способ получения противогрибковых соединений | |
| EA201990455A1 (ru) | КОНДЕНСИРОВАННОЕ ТРИЦИКЛИЧЕСКОЕ ПРОИЗВОДНОЕ γ-АМИНОКИСЛОТЫ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ | |
| EA201600091A1 (ru) | 4-членные кольцевые карбоксамиды, применяемые в качестве нематоцидов | |
| CO2017008600A2 (es) | Análogos de desacetoxitubulisina h, composiciones y método de producción de los mismos | |
| CY1118883T1 (el) | Μεθοδος παρασκευης βορτιοξετινης | |
| UY34111A (es) | Nuevos co-cristales de agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| CY1124083T1 (el) | Κρυσταλλικες μορφες ενος ανταγωνιστη υποδοχεα ανδρογονων, μεθοδος παρασκευης και χρηση αυτων | |
| EA201600121A1 (ru) | Новые индольные и пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их | |
| CY1125143T1 (el) | Νεα αλατα νιλοτινιμπης και πολυμορφα αυτων | |
| CY1122138T1 (el) | Νεα ενωση και διαδικασια | |
| CY1118945T1 (el) | Μεθοδος και ενδιαμεσα για την παρασκευη πρεγκαμπαλινης | |
| CY1124838T1 (el) | Αλας παραγωγου κεφαλοσπορινης, κρυσταλλικη, στερεη μορφη αυτου και μεθοδος παραγωγης αυτου |